Role of Hypothalamic-pituitary-adrenal-axis in Affective Disorders: Anti-depressant and Anxiolytic Activity of Partial 5-HT1A Agonist in Adrenalectomised Rats

par Gupta, Deepali, Radhakrishnan, Mahesh, Bhatt, Shvetank, Kurhe, Yeshwant
Publié 2013

Diabetes-associated depression: The serotonergic system as a novel multifunctional target

par Prabhakar, Visakh, Gupta, Deepali, Kanade, Prateek, Radhakrishnan, Mahesh
Publié dans Indian J Pharmacol (2015)

Pharmacological evaluation of novel 5-HT(3) receptor antagonist, QCM-13 (N-cyclohexyl-3-methoxyquinoxalin-2-carboxamide) as anti-anxiety agent in behavioral test battery

par Gupta, Deepali, Radhakrishnan, Mahesh, Thangaraj, Devadoss, Kurhe, Yeshwant
Publié dans J Pharm Bioallied Sci (2015)

Anti-anxiety effect of a novel 5-HT(3) receptor antagonist N-(benzo[d]thiazol-2-yl)-3-ethoxyquinoxalin-2-carboxamide (6k) using battery tests for anxiety in mice

par Kurhe, Yeshwant Vijay, Radhakrishnan, Mahesh, Thangaraj, Devadoss, Gupta, Deepali
Publié 2014

Neuropharmacological evaluation of a novel 5-HT(3) receptor antagonist (6g) on chronic unpredictable mild stress-induced changes in behavioural and brain oxidative stress parameter...

par Bhatt, Shvetank, Radhakrishnan, Mahesh, Jindal, Ankur, Devadoss, Thangaraj, Dhar, Arghya Kusum
Publié 2014

Antidepressant-like effects of a novel 5-HT3 receptor antagonist 6z in acute and chronic murine models of depression

par Gupta, Deepali, Radhakrishnan, Mahesh, Kurhe, Yeshwant, Thangaraj, Devadoss, Prabhakar, Visakh, Kanade, Prateek
Publié dans Acta Pharmacol Sin (2014)